Hester Biosciences

Hester Biosciences EBIT per Share

The EBIT per Share of Hester Biosciences (HESTERBIO.NS) as of Nov 19, 2026 is 79.68 INR. In the previous year, EBIT per Share was 53.49 INR — a change of 48.95% (higher).

EBIT per Share

79.68INR

YoY

48.95%

Last updated:

EBIT per Share of Hester Biosciences is 2026 79.68 INR. EBIT per Share of Hester Biosciences was 2025 53.49 INR. It decreases by 48.95% higher compared to the previous year.

The Hester Biosciences EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
73.56 INR
Jan 1, 2020
55.08 INR
Jan 1, 2021
66.75 INR
Jan 1, 2022
147.22 INR
Jan 1, 2023
36.47 INR
Jan 1, 2024
41.94 INR
Jan 1, 2025
53.49 INR
Jan 1, 2026
79.68 INR
The Hester Biosciences EBIT per Share history
YEAREBIT per ShareYoY
79.68INR+48.95%
53.49INR+27.53%
41.94INR+15.00%
36.47INR-75.23%
147.22INR+120.56%
66.75INR+21.18%
55.08INR-25.12%
73.56INR+58.15%
46.51INR+28.52%
36.19INR+26.53%
28.60INR+43.26%
19.97INR+27.25%
15.69INR-7.41%
16.95INR-2.10%
17.31INR-1.69%
17.61INR+14.62%
15.36INR+18.36%
12.98INR-18.61%
15.95INR+55.38%
10.26INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hester Biosciences Stock analysis

What does Hester Biosciences do? Hester Biosciences Ltd. generates revenue through its four operational segments: Poultry Healthcare, Animal Healthcare, Petcare, and Others. The company sells poultry vaccines such as Gumboro I, Inactivated ND IB, and Live H120, alongside animal health products including Goat Pox Vaccine and PPR Vaccine - Nigerian 75/1. Petcare offerings like Cefshot Tazo Injection and Hestacef CV target veterinary clinics and pet owners. The firm serves agricultural businesses, veterinary practitioners, and pet care providers across India, with its products distributed through trade channels and direct sales to livestock farmers and clinics. Animal Healthcare segment focuses on livestock protection with vaccines for goats and cattle, while Poultry Healthcare provides specialized immunizations for commercial poultry farms. Diagnostic laboratory services complement the product portfolio, supporting livestock health management. The company's product range caters to both large-scale farming operations and smaller veterinary practices, ensuring consistent demand across its target markets. Revenue streams are derived from direct sales to farmers and veterinary clinics, as well as trade distribution networks. The firm's portfolio includes thermostable vaccines for poultry, such as Thermostable ND, which appeals to commercial poultry producers seeking reliable disease prevention solutions. Petcare products like Hestaflam Tablet are marketed to pet owners and veterinary hospitals, expanding the company's reach beyond traditional agricultural sectors. Hester Biosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hester Biosciences stock

EBIT per Share of Hester Biosciences is 79.68 INR in 2026.

EBIT per Share of Hester Biosciences changed from 53.49 INR to 79.68 INR, representing a 48.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Hester Biosciences since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Hester Biosciences

All Key Metrics — Hester Biosciences